Volume 95 Issue 19 | p. 13 | Concentrates
Issue Date: May 8, 2017

Stem cell specialist takes steps forward

Department: Business
Keywords: personalized medicine, stem cell, partnership, licensing, financing

Magenta Therapeutics has advanced its stem cell transplantation efforts on three levels. It completed a $50 million series B financing round intended to fuel development of products in areas including patient preparation and stem cell harvesting. It in-licensed a Novartis product, MGTA-456, designed to expand the number of cord blood stem cells used in transplants. And it formed a partnership with Be The Match BioTherapies in which it will use Be The Match’s cell therapy delivery platform, clinical trial design, and industry relationships in research efforts.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment